ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 95 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,481 | -35.4% | 4,012 | -9.1% | 0.05% | -33.8% |
Q2 2023 | $124,547 | +43.0% | 4,415 | -12.8% | 0.07% | +54.2% |
Q1 2023 | $87,118 | -38.3% | 5,065 | -27.7% | 0.05% | -35.1% |
Q4 2022 | $141,181 | +35.8% | 7,010 | +45.5% | 0.07% | +80.5% |
Q3 2022 | $104,000 | -22.4% | 4,819 | +0.7% | 0.04% | -18.0% |
Q2 2022 | $134,000 | +34.0% | 4,786 | +120.7% | 0.05% | +11.1% |
Q1 2022 | $100,000 | -48.5% | 2,169 | -5.9% | 0.04% | -38.4% |
Q4 2021 | $194,000 | -23.3% | 2,305 | -39.2% | 0.07% | -34.2% |
Q3 2021 | $253,000 | +19.3% | 3,794 | -5.0% | 0.11% | +27.6% |
Q2 2021 | $212,000 | -15.9% | 3,992 | -31.4% | 0.09% | -17.9% |
Q1 2021 | $252,000 | -15.2% | 5,819 | +1.9% | 0.11% | -13.8% |
Q4 2020 | $297,000 | – | 5,711 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |